Critique of World Health Organization Recommendation of a Dengue Vaccine

被引：41

作者：

Halstead, Scott B. ^{[1
]}

机构：

[1] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Rockville, MD USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2016年 / 214卷 / 12期

关键词：

dengue virus; vaccine; dengue vaccine; pathogenesis; antibody dependent enhancement (ADE); safety; vaccine adverse event;

D O I：

10.1093/infdis/jiw340

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1793 / 1795

页数：3

共 17 条

[1] Epidemiological Factors Associated with Dengue Shock Syndrome and Mortality in Hospitalized Dengue Patients in Ho Chi Minh City, Vietnam [J].

Anders, Katherine L. ;

Nguyen Minh Nguyet ;

Nguyen Van Vinh Chau ;

Nguyen Thanh Hung ;

Tran Thi Thuy ;

Le Bich Lien ;

Jeremy Farrar ;

Bridget Wills ;

Tran Tinh Hien ;

Simmons, Cameron P. .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2011, 84 (01) :127-134

[2] Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial [J].

Capeding, Maria Rosario ;

Ngoc Huu Tran ;

Hadinegoro, Sri Rezeki S. ;

Ismail, Hussain Imam H. J. Muhammad ;

Chotpitayasunondh, Tawee ;

Chua, Mary Noreen ;

Chan Quang Luong ;

Rusmil, Kusnandi ;

Wirawan, Dewa Nyoman ;

Nallusamy, Revathy ;

Pitisuttithum, Punnee ;

Thisyakorn, Usa ;

Yoon, In-Kyu ;

van der Vliet, Diane ;

Langevin, Edith ;

Laot, Thelma ;

Hutagalung, Yanee ;

Frago, Carina ;

Boaz, Mark ;

Wartel, T. Anh ;

Tornieporth, Nadia G. ;

Saville, Melanie ;

Bouckenooghe, Alain .

LANCET, 2014, 384 (9951) :1358-1365

[3]

Coudeville L, 2016, VACCINE IN PRESS

[4] Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward [J].

Guy, Bruno ;

Briand, Olivier ;

Lang, Jean ;

Saville, Melanie ;

Jackson, Nicholas .

VACCINE, 2015, 33 (50) :7100-7111

[5]

Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X

[6] DENGUE HEMORRHAGIC-FEVER IN CUBA, 1981 - A RETROSPECTIVE SEROEPIDEMIOLOGIC STUDY [J].

GUZMAN, MG ;

KOURI, GP ;

BRAVO, J ;

SOLER, M ;

VAZQUEZ, S ;

MORIER, L .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1990, 42 (02) :179-184

[7]

Guzman MG., 2002, PAHO J EPIDEMIOL, V81, P223

[8] Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease [J].

Hadinegoro, S. R. ;

Arredondo-Garcia, J. L. ;

Capeding, M. R. ;

Deseda, C. ;

Chotpitayasunondh, T. ;

Dietze, R. ;

Ismail, H. I. Hj Muhammad ;

Reynales, H. ;

Limkittikul, K. ;

Rivera-Medina, D. M. ;

Tran, H. N. ;

Bouckenooghe, A. ;

Chansinghakul, D. ;

Cortes, M. ;

Fanouillere, K. ;

Forrat, R. ;

Frago, C. ;

Gailhardou, S. ;

Jackson, N. ;

Noriega, F. ;

Plennevaux, E. ;

Wartel, T. A. ;

Zambrano, B. ;

Saville, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13) :1195-1206

[9] Neutralization and antibody-dependent enhancement of dengue viruses [J].

Halstead, SB .

FLAVIVIRUSES: PATHOGENESIS AND IMMUNITY, 2003, 60 :421-467

[10] Protective and immunological behavior of chimeric yellow fever dengue vaccine [J].

Halstead, Scott B. ;

Russell, Philip K. .

VACCINE, 2016, 34 (14) :1643-1647

← 1 2 →